This item is under embargo and not available online per the author's request. For access information, please visit http://libanswers.wustl.edu/faq/5640.

Date of Award

Winter 1-15-2021

Author's School

Graduate School of Arts and Sciences

Author's Department

Chemistry

Degree Name

Doctor of Philosophy (PhD)

Degree Type

Dissertation

Abstract

Antibiotics have greatly reduced the number of deaths caused by infectious diseases for the last 70 years, but as a result of overuse, antimicrobial resistance emerged. Resistance is the major reason why most traditional antibiotics currently have reduced clinical efficacy. However, there is still a drive to overcome this resistance in a variety of ways. There are two main avenues of research to overcome resistance; to discover and develop new drug candidates acting on new targets and pathways, and to determine the mechanisms of antibiotic resistance in order to combat it through multi-drug therapies, bringing back the effectiveness of antibiotics used in the past. My research uses both approaches to address the antibiotic resistance crisis with an emphasis on leveraging mechanistic enzymology to inspire the development of new antibacterial therapeutic strategies.

Language

English (en)

Chair and Committee

Timothy Wencewicz

Committee Members

John-Stephen Taylor, Gautam Dantas, Jeffrey Henderson, Meredith Jackrel,

Available for download on Friday, January 06, 2023

Included in

Biochemistry Commons

Share

COinS